" class="no-js "lang="en-US"> Amniotics Archives - Medtech Alert
Tuesday, June 06, 2023

Sort by:

Date

Top Post

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy

SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]

Amniotics Receives Approval for Phase I/II Study of Pulmostem™ in Hospitalized COVID-19 Patients

Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that it has received approval by regulatory […]

Amniotics Strengthens its Clinical and Regulatory Capabilities

Amniotics AB (publ) (Nasdaq Stockholm: AMNI), a developer of novel cell therapy products, has appointed […]

Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies

Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that it has received a non-diluting grant […]

Amniotics Joins Vinnova Funded ’CAMP’ to Improve Outcome of Lung Transplantations with PulmoStem™

Amniotics AB (publ) (Nasdaq Stockholm: AMNI), a developer of novel cell therapy products, today announced that […]

Stem Cell Therapy Company Amniotics Raises SEK 60 Million

Amniotics AB (publ) (“Amniotics” or the “Company”), a stem cell therapy company has raised SEK60 million through […]

  1. RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings Read more
  2. Visgenx Appoints William Pedranti as Chief Executive Officer Read more
  3. Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia Read more
  4. The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease Read more
  5. ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities Read more